Transforming Pediatric Rare Disease Trials Through Modeling and Simulation and Site Networks
Shreya Yeramilli
Drug developers face unique challenges in pediatric rare disease trials, including small and geographically dispersed patient populations, strict ethical limits on sampling, and sparse early clinical data. In a competitive landscape where speed is critical and every month can influence funding rounds and regulatory milestones; traditional development approaches often fall short. However, forward-thinking strategies are transforming these challenges into […] The post Transforming Pediatric Rare D